U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197775) titled 'Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)' on Sept. 26.
Brief Summary: This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
Study Start Date: Oct., 2025
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes Mellitus (T2DM)
Type2Diabetes
Diabetes Mellitus, Type 2
Type 2 Diabetes
Diabetes
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Endogenex, Inc.
Disclaimer: Curated by HT Syndication....